Skip to main content
SpringerLink
Log in

Role of Endoscopy in the Diagnosis, Staging, and Management of Esophageal Cancer

  • Chapter
  • First Online:
Esophageal Cancer

  • 1053 Accesses

Abstract

The incidence of esophageal adenocarcinoma (EAC) has increased approximately 700% since the late 1970s with over 10,000 cases diagnosed annually, outpacing the rate of growth of other major epithelial malignancies. Meanwhile, the incidence of esophageal squamous cell carcinoma (ESCC) has declined over several decades. While SCC is not felt to be preceded by a premalignant condition amenable to screening, EAC is preceded by Barrett’s esophagus (BE) in a metaplasia-dysplasia-carcinoma sequence. BE has been a target for screening efforts and eradication via endoscopic approaches in order to detect and prevent EAC. The risk of developing EAC among patients with non-dysplastic BE is approximately 0.4–0.5% per year but is much higher in patients with high-grade dysplasia. The relatively good 5-year prognosis in early-stage disease has led to efforts aimed at detecting progression to cancer or dysplasia in patients with BE. Screening is recommended for patients with non-dysplastic BE. For patients that progress to dysplasia, the current standard approach involves endoscopic mucosal resection and radiofrequency ablation. Highly select early esophageal cancers may in some cases also be managed endoscopically. The use of endoscopy for the prevention, diagnosis, and treatment of esophageal cancer continues to evolve.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gamboa AM, et al. Mo1135 trends in the incidence of esophageal adenocarcinoma and early stage esophageal adenocarcinoma in the United States. Gastroenterology. 2014;146(5):S-566–7.

    Article  Google Scholar 

  2. Siegel R, Naishadham D. Cancer statistics, 2013. CA A Cancer J. 2013;63(1):11–30. http://onlinelibrary.wiley.com/doi/10.3322/caac.21166/full?dmmsmid=68954&dmmspid=8282470&dmmsuid=1829598%5Cnpapers2://publication/uuid/1268646D-F787-441F-B50E-43B02A2D9FB3

    Article  Google Scholar 

  3. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97(2):142–6.

    Article  PubMed  Google Scholar 

  4. Sappati Biyyani RS, Chak A. Barrett’s esophagus: review of diagnosis and treatment. Gastroenterol Rep. 2013;1(1):9–18. http://www.ncbi.nlm.nih.gov/pubmed/24759662%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3941437

    Article  Google Scholar 

  5. Association AG. American gastroenterological association medical position statement on the management of Barrett’S esophagus. Gastroenterology. 2011;140(3):1084–91. https://doi.org/10.1053/j.gastro.2011.01.030.

    Article  Google Scholar 

  6. Mino-Kenudson M, Hull MJ, Brown I, Muzikansky A, Srivastava A, Glickman J, et al. EMR for Barrett’s esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy {a figure is presented}. Gastrointest Endosc. 2007;66(4):660–6.

    Article  PubMed  Google Scholar 

  7. Rice TW, Blackstone EH, Adelstein DJ, Zuccaro G, Vargo JJ, Goldblum JR, et al. Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. J Thorac Cardiovasc Surg. 2003;125(5):1091–102.

    Article  PubMed  Google Scholar 

  8. Fitzgerald RC, Di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42.

    Article  PubMed  Google Scholar 

  9. Green JA, Amaro R, Barkin JS. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. Dig Dis Sci. 2000;45:2367–8.

    Article  CAS  PubMed  Google Scholar 

  10. Lagergren J, Bergstromeinhold R, Lingren A, Nyren O. Symptomatic gastoroesophageal reflux as a risk factor for esophageal adenocarcinoma. NEJM. 1999;340:825–31.

    Article  CAS  PubMed  Google Scholar 

  11. Shaheen NJ, Weinberg DS, Denberg TD, Chou R, Qaseem A, Shekelle P. Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the american college of physicians. Ann Intern Med. 2012;157:808–17.

    Article  PubMed  Google Scholar 

  12. Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG clinical guideline: diagnosis and management of Barrett/‘s esophagus [internet]. Am J Gastroenterol. 2016;111:30–50. https://doi.org/10.1038/ajg.2015.322.

    Article  CAS  PubMed  Google Scholar 

  13. Reavis KM, Morris CD, Gopal DV, Hunter JG, Jobe BA, Schirmer BD, et al. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms. Annals of Surgery. 2004;239(6):849–58.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360(22):2277–88. https://doi.org/10.1056/NEJMoa0808145.

    Article  CAS  PubMed  Google Scholar 

  15. Rex DK, Cummings OW, Shaw M, Cumings MD, Wong RKH, Vasudeva RS, et al. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology. 2003;125(6):1670–7.

    Article  PubMed  Google Scholar 

  16. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129(6):1825–31.

    Article  PubMed  Google Scholar 

  17. Atkinson M, Chak A. Unsedated small-caliber endoscopy--a new screening and surveillance tool for Barrett’s esophagus? Nat Clin Pr Gastroenterol Hepatol. 2007;4(8):426–7.

    Article  Google Scholar 

  18. Galmiche JP, Sacher-Huvelin S, Coron E, Cholet F, Ben SE, Sébille V, et al. Screening for esophagitis and Barrett’s esophagus with wireless esophageal capsule endoscopy: a multicenter prospective trial in patients with reflux symptoms. Am J Gastroenterol. 2008;103(3):538–45.

    Article  PubMed  Google Scholar 

  19. Chak A, Alashkar BM, Isenberg GA, Chandar AK, Greer KB, Hepner A, et al. Comparative acceptability of transnasal esophagoscopy and esophageal capsule esophagoscopy: a randomized, controlled trial in veterans. Gastrointest Endosc. 2014;80(5):774–82.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Aedo MR, Zavala-González MÁ, Meixueiro-Daza A, Remes-Troche JM. Accuracy of transnasal endoscopy with a disposable esophagoscope compared to conventional endoscopy. World J Gastrointest Endosc. 2014;6(4):128–36. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3985153&tool=pmcentrez&rendertype=abstract.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kadri PSR, Lao-Sirieix I, O’Donovan M, Debiram I, Das M, Blazeby JM, et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett’s oesophagus in primary care: cohort study. BMJ. 2010;341(7773):595.

    Google Scholar 

  22. Ross-Innes CS, Debiram-Beecham I, O’Donovan M, Walker E, Varghese S, Lao-Sirieix P, et al. Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett’s esophagus: a multi-center case-control study. PLoS Med. 2015;12(1):e1001780.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Streitz JM, Ellis FH, Tilden RL, Erickson RV. Endoscopic surveillance of Barrett’s esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol. 1998;93(6):911–5.

    Article  PubMed  Google Scholar 

  24. Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365(15):1375–83. http://www.ncbi.nlm.nih.gov/pubmed/21995385%5Cnhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa1103042

    Article  CAS  PubMed  Google Scholar 

  25. Komanduri S, Swanson G, Keefer L, Jakate S. Use of a new jumbo forceps improves tissue acquisition of Barrett’s esophagus surveillance biopsies. Gastrointest Endosc. 2009;70(6):1072–8.e1.

    Article  PubMed  Google Scholar 

  26. Abela JE, Going JJ, Mackenzie JF, McKernan M, O’Mahoney S, Stuart RC. Systematic four-quadrant biopsy detects Barrett’s dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol. 2008;103(4):850–5.

    Article  PubMed  Google Scholar 

  27. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103:788–97.

    Article  PubMed  Google Scholar 

  28. Sharma P. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131(5):1392–9.

    Article  PubMed  Google Scholar 

  29. Haidry RJ, Dunn JM, Butt MA, Burnell MG, Gupta A, Green S, et al. Radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrett’s esophagus and early esophageal adenocarcinoma: outcomes of the UK national halo RFA registry. Gastroenterology. 2013;145(1):87–95.

    Article  PubMed  Google Scholar 

  30. Phoa KN, van Vilsteren FGI, Weusten BLAM, Bisschops R, Schoon EJ, Ragunath K, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia. JAMA. 2014;311(12):1209. http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2014.2511

    Article  CAS  PubMed  Google Scholar 

  31. Phoa KN, Pouw RE, Bisschops R, Pech O, Ragunath K, Weusten BLAM, et al. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II). Gut. 2016;65(4):555–62.

    Article  CAS  PubMed  Google Scholar 

  32. Haidry RJ, Lipman G, Banks MR, Butt MA, Sehgal V, Graham D, et al. Comparing outcome of radiofrequency ablation in Barrett’s with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry. Endoscopy. 2015;47(11):980–7.

    Article  PubMed  Google Scholar 

  33. Weusten B, Bisschops R, Coron E, Dinis-Ribeiro M, Dumonceau J-M, Esteban J-M, et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement. Endoscopy. 2017;49(2):191–8. http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-122140

    Article  PubMed  Google Scholar 

  34. Akiyama J, Roorda A, Triadafilopoulos G. Managing Barrett’s esophagus with radiofrequency ablation. Gastroenterol Rep. 2013;1(2):95–104. https://academic.oup.com/gastro/article-lookup/doi/10.1093/gastro/got009

    Article  Google Scholar 

  35. Lichtenstein DR. Role of endoscopy in the management of GERD. Gastrointest Endosc. 2007;66(2):219–24.

    Article  PubMed  Google Scholar 

  36. Triadafilopoulos G. Clinical experience with the Stretta® procedure. Gastrointest Endosc Clin N Am. 2003;13:147–55.

    Article  PubMed  Google Scholar 

  37. Bianco MA, et al. Endoscopic treatment of gastro-oesophageal reflux disease. Acta Otorhinolaryngol Ital. 2006;26(5):281–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Utley DS. The Stretta® procedure: device, technique, and pre-clinical study data. Gastrointest Endosc Clin N Am. 2003;13:135–45.

    Article  PubMed  Google Scholar 

  39. Arts J, Lerut T, Rutgeerts P, Sifrim D, Janssens J, Tack J. A one-year follow-up study of endoluminal gastroplication (Endocinch) in GERD patients refractory to proton pump inhibitor therapy. Dig Dis Sci. 2005;50(2):351–6.

    Article  CAS  PubMed  Google Scholar 

  40. Arts J, Sifrim D, Rutgeerts P, Lerut A, Janssens J, Tack J. Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophagal reflux disease. Dig Dis Sci. 2007;52(9):2170–7.

    Article  CAS  PubMed  Google Scholar 

  41. Singh PB, Das SK, Kumar A, Sharma GK, Pandey AK, Swain S, et al. Dorsal onlay lingual mucosal graft urethroplasty: comparison of two techniques. Int J Urol. 2008;15(11):1002–5.

    Article  PubMed  Google Scholar 

  42. Chuttani R, Sud R, Sachdev G, Puri R, Kozarek R, Haber G, et al. A novel endoscopic full-thickness plicator for the treatment of GERD: a pilot study. Gastrointest Endosc. 2003;58(5):770–6.

    Article  PubMed  Google Scholar 

  43. Pleskow D, Rothstein R, Kozarek R, Haber G, Gostout C, Lo S, et al. Endoscopic full-thickness plication for the treatment of GERD: five-year long-term multicenter results. Surg Endosc Other Interv Tech. 2008;22(2):326–32.

    Article  Google Scholar 

  44. Von Renteln D, Schiefke I, Fuchs KH, Raczynski S, Philipper M, Breithaupt W, et al. Endoscopic full-thickness plication for the treatment of gastroesophageal reflux disease using multiple Plicator implants: 12-month multicenter study results. Surg Endosc Other Interv Tech. 2009;23(8):1866–75.

    Article  Google Scholar 

  45. Leeds S, Reavis K. Endolumenal therapies for gastroesophageal reflux disease. Gastrointest Endosc Clin N Am. 2013;23:41–51.

    Article  PubMed  Google Scholar 

  46. Reavis KM, Perry KA. Transoral incisionless fundoplication for the treatment of gastroesophageal reflux disease. Expert Rev Med Devices. 2014;11(4):341–50.

    Article  CAS  PubMed  Google Scholar 

  47. Louis H, Closset J, Deviere J. Enteryx. Best Pract Res Clin Gastroenterol. 2004;18(1):49–59.

    Article  PubMed  Google Scholar 

  48. Johnson DA. Enteryx® for gastroesophageal reflux disease. Expert Rev Med Devices. 2005;2(1):19–26.

    Article  PubMed  Google Scholar 

  49. Deviére J, Pastorelli A, Louis H, De Maertelaer V, Lehman G, Cicala M, et al. Endoscopic implantation of a biopolymer in the lower esophageal sphincter for gastroesophageal reflux: a pilot study. Gastrointest Endosc. 2002;55(3):335–41.

    Article  PubMed  Google Scholar 

  50. Corley DA, Katz P, Wo JM, Stefan A, Patti M, Rothstein R, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003;125(3):668–76.

    Article  PubMed  Google Scholar 

  51. Tam WCE, Schoeman MN, Zhang Q, Dent J, Rigda R, Utley D, et al. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut. 2003;52(4):479–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Dughera L, Rotondano G, De Cento M, Cassolino P, Cisarò F. Durability of stretta radiofrequency treatment for GERD: results of an 8-year follow-up. Gastroenterol Res Pract. 2014;2014

    Google Scholar 

  53. Wiersema MJ, Levy MJ, Harewood GC, Gostout CJ. Cost analysis of endoscopic antireflux procedures: Endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor [1] (multiple letters). Gastrointest Endosc. 2004;59:749–50.

    Article  PubMed  Google Scholar 

  54. Fry LC, Monkemuller K, Malfertheiner P. Systematic review: endoluminal therapy for gastro-oesophageal reflux disease: evidence from clinical trials. Eur J Gastroenterol Hepatol. 2007;19(12):1125–39.

    Article  PubMed  Google Scholar 

  55. Espino A, Cirocco M, DaCosta R, Marcon N. Advanced imaging technologies for the detection of dysplasia and early cancer in Barrett Esophagus. Clin Endosc. 2014;47(1):47–54.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Curvers WL, Peters FP, Elzer B, Schaap AJCM, Baak LC, Van Oijen A, et al. Quality of Barrett’s surveillance in The Netherlands: a standardized review of endoscopy and pathology reports. Eur J Gastroenterol Hepatol. 2008;20(7):601–7.

    Article  PubMed  Google Scholar 

  57. Ramus JR, Caygill CPJ, Gatenby PAC, Watson A. Current United Kingdom practice in the diagnosis and management of columnar-lined oesophagus: results of the United Kingdom National Barrett Oesophagus Registry endoscopist questionnaire. Eur J Cancer Prev. 2008;17(5):422–5.

    Article  PubMed  Google Scholar 

  58. Das D, Ishaq S, Harrison R, Kosuri K, Harper E, DeCaestecker J, et al. Management of Barrett’s esophagus in the UK: Overtreated and underbiopsied but improved by the introduction of a national randomized trial. Am J Gastroenterol. 2008;103(5):1079–89.

    Article  PubMed  Google Scholar 

  59. Garud SS, Willingham FF, Cai Q. Diagnosis and management of Barrett’s esophagus for the endoscopist. Ther Adv Gastroenterol. 2010;3:227–38.

    Article  Google Scholar 

  60. Alderson D. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma: another spanner in the works? Gut. 2002;51:620–1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Kara MA, Peters FP, Fockens P, ten Kate FJW, Bergman JJGHM. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett’s esophagus. Gastrointest Endosc. 2006;64(2):176–85.

    Article  PubMed  Google Scholar 

  62. Gono K, Obi T, Yamaguchi M, Ohyama N, Machida H, Sano Y, et al. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt. 2004;9(3):568. http://biomedicaloptics.spiedigitallibrary.org/article.aspx?doi=10.1117/1.1695563

    Article  PubMed  Google Scholar 

  63. Mannath J, Subramanian V, Hawkey CJ, Ragunath K. Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barretts esophagus: a meta-analysis. Endoscopy. 2010;42(5):351–9.

    Article  CAS  PubMed  Google Scholar 

  64. Sharma P, Hawes RH, Bansal A, Gupta N, Curvers W, Rastogi A, et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: a prospective, international, randomised controlled trial. Gut. 2013;62(1):15–21.

    Article  PubMed  Google Scholar 

  65. Herrero LA, Curvers WL, Bansal A, Wani S, Kara M, Schenk E, et al. Zooming in on Barrett oesophagus using narrow-band imaging: an international observer agreement study. Eur J Gastroenterol Hepatol. 2009;21(9):1068–75.

    Article  Google Scholar 

  66. Curvers WL, Bohmer CJ, Mallant-Hent RC, Naber AH, Ponsioen CIJ, Ragunath K, et al. Mucosal morphology in Barrett’s esophagus: Interobserver agreement and role of narrow band imaging. Endoscopy. 2008;40(10):799–805.

    Article  CAS  PubMed  Google Scholar 

  67. Silva FB, Dinis-Ribeiro M, Vieth M, Rabenstein T, Goda K, Kiesslich R, et al. Endoscopic assessment and grading of Barrett’s esophagus using magnification endoscopy and narrow-band imaging: accuracy and interobserver agreement of different classification systems (with videos). Gastrointest Endosc. 2011;73(1):7–14.

    Article  PubMed  Google Scholar 

  68. Leggett CL, Gorospe EC. Application of confocal laser endomicroscopy in the diagnosis and management of Barrett’s esophagus. Ann Gastroenterol Q Publ Hell Soc Gastroenterol. 2014;27(3):193–9.

    Google Scholar 

  69. Kiesslich R, Gossner L, Goetz M, Dahlmann A, Vieth M, Stolte M, et al. In vivo histology of Barrett’s esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol. 2006;4(8):979–87.

    Article  PubMed  Google Scholar 

  70. Canto MI, Anandasabapathy S, Brugge W, Falk GW, Dunbar KB, Zhang Z, et al. In vivo endomicroscopy improves detection of Barrett’s esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointest Endosc. 2014;79(2):211–21.

    Article  PubMed  Google Scholar 

  71. Sharma P, Meining AR, Coron E, Lightdale CJ, Wolfsen HC, Bansal A, et al. Real-time increased detection of neoplastic tissue in Barrett’s esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc. 2011;74(3):465–72.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Bajbouj M, Vieth M, Rösch T, Miehlke S, Becker V, Anders M, et al. Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barretts esophagus. Endoscopy. 2010;42(6):435–40.

    Article  CAS  PubMed  Google Scholar 

  73. Xiong YQ, Ma SJ, Hu HY, Ge J, Zhou LZ, Huo ST, Qiu MCQ. Comparison of narrow-band imaging and confocal laser endomicroscopy for the detection of neoplasia in Barrett’s esophagus: a meta-analysis. Clin Res Hepatol Gastroenterol. 2017;S2210(17):30136–5.

    Google Scholar 

  74. Lee MH, Buterbaugh K, Richards-Kortum R, Anandasabapathy S. Advanced endoscopic imaging for Barrett’s esophagus: current options and future directions. Curr Gastroenterol Rep. 2012;14(3):216–25.

    Article  PubMed  Google Scholar 

  75. Isenberg G, Sivak MV, Chak A, Wong RCK, Willis JE, Wolf B, et al. Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett’s esophagus: a prospective, double-blinded study. Gastrointest Endosc. 2005;62(6):825–31.

    Article  PubMed  Google Scholar 

  76. Qi X, Sivak MV, Isenberg G, Willis JE, Rollins AM. Computer-aided diagnosis of dysplasia in Barrett’s esophagus using endoscopic optical coherence tomography. J Biomed Opt. 2006;11(4):44010. http://biomedicaloptics.spiedigitallibrary.org/article.aspx?doi=10.1117/1.2337314

    Article  Google Scholar 

  77. Gill RS, Singh R. Endoscopic imaging in Barrett’s esophagus: current practice and future applications. Ann Gastroenterol Q Publ Hell Soc Gastroenterol. 2012;25(2):89–95. http://www.ncbi.nlm.nih.gov/pubmed/24714225%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3959381

    Google Scholar 

  78. Evans JA, Poneros JM, Bouma BE, Bressner J, Halpern EF, Shishkov M, et al. Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett’s esophagus. Clin Gastroenterol Hepatol. 2006;4:38–43.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Clermont MP, et al. Impact of endoscopic mucosal resection in patients referred for endoscopic management of Barrett’s esophagus. Gastrointest Interv. 2013;2(2):90–3.

    Article  Google Scholar 

  80. Moss A, Bourke MJ, Hourigan LF, Gupta S, Williams SJ, Tran K, et al. Endoscopic resection for Barrett’s high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. Am J Gastroenterol. 2010;105(6):1276–83.

    Article  PubMed  Google Scholar 

  81. Shimizu Y, Kato M, Yamamoto J, Ono Y, Katsurada T, Ono S, et al. Histologic results of EMR for esophageal lesions diagnosed as high-grade intraepithelial squamous neoplasia by endoscopic biopsy. Gastrointest Endosc. 2006;63:16–21.

    Article  PubMed  Google Scholar 

  82. Pech O, May A, Gossner L, Rabenstein T, Manner H, Huijsmans J, et al. Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy. 2007;39(1):30–5. http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=17252457&retmode=ref&cmd=prlinks%5Cnpapers3://publication/doi/10.1055/s-2006-945040

    Article  CAS  PubMed  Google Scholar 

  83. Savoy AD, Wallace MB. EUS in the management of the patient with dysplasia in Barrett’s esophagus. J Clin Gastroenterol. 2005;39(4):263–7.

    Article  PubMed  Google Scholar 

  84. Attila T, Faigel DO. Role of endoscopic ultrasound in superficial esophageal cancer. Dis Esophagus. 2009;22(2):104–12. http://www.ncbi.nlm.nih.gov/pubmed/19021687

    Article  PubMed  Google Scholar 

  85. Thomas T, Gilbert D, Kaye PV, Penman I, Aithal GP, Ragunath K. High-resolution endoscopy and endoscopic ultrasound for evaluation of early neoplasia in Barrett’s esophagus. Surg Endosc Other Interv Tech. 2010;24(5):1110–6.

    Article  CAS  Google Scholar 

  86. Vazquez-Sequeiros E, Wiersema MJ, Clain JE, Norton ID, Levy MJ, Romero Y, et al. Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology. 2003;125(6):1626–35.

    Article  PubMed  Google Scholar 

  87. Pech O, May A, Günter E, Gossner L, Ell C. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett’s esophagus. Am J Gastroenterol. 2006;101(10):2223–9.

    Article  PubMed  Google Scholar 

  88. Larghi A, Lightdale CJ, Memeo L, Bhagat G, Okpara N, Rotterdam H. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett’s esophagus. Gastrointest Endosc. 2005;62(1):16–23.

    Article  PubMed  Google Scholar 

  89. Rampado S, Bocus P, Battaglia G, Ruol A, Portale G, Ancona E. Endoscopic ultrasound: accuracy in staging superficial carcinomas of the esophagus. Ann Thorac Surg. 2008;85(1):251–6.

    Article  PubMed  Google Scholar 

  90. Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc. 2002;56(3):387–90.

    Article  PubMed  Google Scholar 

  91. He LJ, Shan HB, Luo GY, Li Y, Zhang R, Gao XY, et al. Endoscopic ultrasonography for staging of T1a and T1b esophageal squamous cell carcinoma. World J Gastroenterol. 2014;20(5):1340–7.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Wani S, Das A, Rastogi A, Drahos J, Ricker W, Parsons R, et al. Endoscopic ultrasonography in esophageal cancer leads to improved survival rates: results from a population-based study. Cancer. 2015;121(2):194–201.

    Article  PubMed  Google Scholar 

  93. Bailey BE, Freedenfeld RN, Kiser RS, Gatchel RJ. Lifetime physical and sexual abuse in chronic pain patients: psychosocial correlates and treatment outcomes. Disabil Rehabil. 2003;25(7):331–42.

    Article  CAS  PubMed  Google Scholar 

  94. Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, et al. Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a delphi process. Gastroenterology. 2012;143(2):336–46.

    Article  PubMed  Google Scholar 

  95. Markar SR, Karthikesalingam A, Thrumurthy S, Low DE. Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000-2011. J Gastrointest Surg. 2012;16:1055–63.

    Article  PubMed  Google Scholar 

  96. Ell C, May A, Gossner L, Pech O, Günter E, Mayer G, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology. 2000;118(4):670–7. http://www.ncbi.nlm.nih.gov/pubmed/10734018

    Article  CAS  PubMed  Google Scholar 

  97. Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Hölscher AH. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg. 2011;254(1):67–72.

    Article  PubMed  Google Scholar 

  98. Prasad GA, Wu TT, Wigle DA, Buttar NS, Wongkeesong LM, Dunagan KT, et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett’s esophagus. Gastroenterology. 2009;137(3):815–23.

    Article  PubMed  Google Scholar 

  99. Das A, et al. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol. 2008;103(6):1340–5.

    Article  PubMed  Google Scholar 

  100. Wani S, Drahos J, Cook MB, Rastogi A, Bansal A, Yen R, et al. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointest Endosc. 2014;79(2):224–232.e1.

    Article  PubMed  Google Scholar 

  101. Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut. 2008;57(9):1200–6.

    Article  CAS  PubMed  Google Scholar 

  102. Larghi A, Lightdale CJ, Ross AS, Fedi P, Hart J, Rotterdam H, et al. Long-term follow-up of complete Barrett’s eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy. 2007;39(12):1086–91.

    Article  CAS  PubMed  Google Scholar 

  103. Ell C, May A, Pech O, Gossner L, Guenter E, Behrens A, et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest Endosc. 2007;65(1):3–10.

    Article  PubMed  Google Scholar 

  104. May A, Gossner L, Pech O, Müller H, Vieth M, Stolte M, et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett’s esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy. 2002;34(8):604–10.

    Article  CAS  PubMed  Google Scholar 

  105. Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M, et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology. 2014;146(3):652–660.e1.

    Article  PubMed  Google Scholar 

  106. Manner H, Pech O, Heldmann Y, May A, Pohl J, Behrens A, et al. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol. 2013;11(6):630–5.

    Article  PubMed  Google Scholar 

  107. Gamboa AM, Kim S, Woods KE, Force SD, Maithel SK, Staley C, et al. Treatment allocation in early stage esophageal adenocarcinoma: the national incidence rates and predictors of lymph node involvement. Gastrointest Endosc. 2014;79(5):AB133. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L71429238%5Cnhttp://dx.doi.org/10.1016/j.gie.2014.02.083%5Cnhttp://ca3cx5qj7w.search.serialssolutions.com?sid=EMBASE&issn=00165107&id=doi:10.1016%2Fj.gie.2014.02.083&atitle=Treatment+alloc

    Article  Google Scholar 

  108. Esaki M, Matsumoto T, Hirakawa K, Nakamura S, Umeno J, Koga H, et al. Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection. Endoscopy. 2007;39(1):41–5.

    Article  CAS  PubMed  Google Scholar 

  109. Pech O, Manner H, Ell C. Endoscopic resection. Gastrointest Endosc Clin N Am. 2011;21(1):81–94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=21112499

    Article  PubMed  Google Scholar 

  110. Konda VJA, Gonzalez Haba Ruiz M, Koons A, Hart J, Xiao SY, Siddiqui UD, et al. Complete endoscopic mucosal resection is effective and durable treatment for barrett’s-associated neoplasia. Clin Gastroenterol Hepatol. 2014;12(12):2002–10.

    Article  PubMed  Google Scholar 

  111. Ancona E, Rampado S, Cassaro M, Battaglia G, Ruol A, Castoro C, et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol. 2008;15(11):3278–88.

    Article  PubMed  Google Scholar 

  112. Westerterp M, Koppert LB, Buskens CJ, Tilanus HW, ten Kate FJW, JJHGM B, et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch. 2005;446(5):497–504. http://www.ncbi.nlm.nih.gov/pubmed/15838647

    Article  PubMed  Google Scholar 

  113. Eguchi T, Nakanishi Y, Shimoda T, Iwasaki M, Igaki H, Tachimori Y, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006;19(3):475–80.

    Article  PubMed  Google Scholar 

  114. Honda K, Akiho H. Endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. World J Gastrointest Pathophysiol. 2012;3(2):44–50.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Takahashi H, Arimura Y, Masao H, Okahara S, Tanuma T, Kodaira J, et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc. 2010;72(2):255–64.

    Article  PubMed  Google Scholar 

  116. Ishihara R, Iishi H, Takeuchi Y, Kato M, Yamamoto S, Yamamoto S, et al. Local recurrence of large squamous-cell carcinoma of the esophagus after endoscopic resection. Gastrointest Endosc. 2008;67(6):799–804.

    Article  PubMed  Google Scholar 

  117. Almond LM, Hodson J, Barr H. Meta-analysis of endoscopic therapy for low-grade dysplasia in Barrett’s oesophagus. Br J Surg. 2014;101:1187–95.

    Article  CAS  PubMed  Google Scholar 

  118. Chadwick G, Groene O, Markar SR, Hoare J, Cromwell D, Hanna GB. Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett’s esophagus: a critical assessment of histologic outcomes and adverse events. Gastrointest Endosc. 2014;79:718–731.e3.

    Article  PubMed  Google Scholar 

  119. Evans JA, Early DS, Fukami N, Ben-Menachem T, Chandrasekhara V, Chathadi KV, et al. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76(6):1087–94.

    Article  PubMed  Google Scholar 

  120. Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for barrett’s esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1245–55.

    Article  PubMed  Google Scholar 

  121. Strauss AC, Agoston AT, Dulai PS, Srivastava A, Rothstein RI. Radiofrequency ablation for Barrett’s-associated intramucosal carcinoma: a multi-center follow-up study. Surg Endosc Other Interv Tech. 2014;28(12):3366–72.

    Article  Google Scholar 

  122. Titi M, Overhiser A, Ulusarac O, Falk GW, Chak A, Wang K, et al. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett’s esophagus. Gastroenterology. 2012;143(3):564–566.e1.

    Article  PubMed  Google Scholar 

  123. Kim HP, et al. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett’s esophagus with advanced neoplasia. Gastrointest Endosc. 2012;76(4):733–9.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Bulsiewicz WJ, Kim HP, Dellon ES, Cotton CC, Pasricha S, Madanick RD, et al. Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic barrett’s esophagus. Clin Gastroenterol Hepatol. 2013;11(6):636–42.

    Article  PubMed  Google Scholar 

  125. Li N, Pasricha S, Bulsiewicz WJ, Pruitt RE, Komanduri S, Wolfsen HC, et al. Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett’s esophagus: results from the United States radiofrequency ablation registry. Dis Esophagus. 2016;29(6):537–43.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

    Michelle P. Clermont

  2. Department of Medicine, Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA, USA

    Field F. Willingham

Authors
  1. Michelle P. Clermont
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Field F. Willingham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Field F. Willingham .

Editor information

Editors and Affiliations

  1. Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, GA, USA

    Nabil F. Saba

  2. Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, GA, USA

    Bassel F. El-Rayes

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Clermont, M.P., Willingham, F.F. (2020). Role of Endoscopy in the Diagnosis, Staging, and Management of Esophageal Cancer. In: Saba, N., El-Rayes, B. (eds) Esophageal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-29832-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-29832-6_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-29831-9

  • Online ISBN: 978-3-030-29832-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation